Literature DB >> 15530543

IR-inducible clusterin gene expression: a protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects.

Dmitry Klokov1, Tracy Criswell, Konstantin S Leskov, Shinako Araki, Lindsey Mayo, David A Boothman.   

Abstract

Clusterin (CLU) plays numerous roles in mammalian cells after stress. A review of the recent literature strongly suggests potential roles for CLU proteins in low dose ionizing radiation (IR)-inducible adaptive responses, bystander effects, and delayed death and genomic instability. Its most striking and evident feature is the inducibility of the CLU promoter after low, as well as high, doses of IR. Two major forms of CLU, secreted (sCLU) and nuclear (nCLU), possess opposite functions in cellular responses to IR: sCLU is cytoprotective, whereas nCLU (a byproduct of alternative splicing) is a pro-death factor. Recent studies from our laboratory and others demonstrated that down-regulation of sCLU by specific siRNA increased cytotoxic responses to chemotherapy and IR. sCLU was induced after low non-toxic doses of IR (0.02-0.5 Gy) in human cultured cells and in mice in vivo. The low dose inducibility of this survival protein suggests a possible role for sCLU in radiation adaptive responses, characterized by increased cell radioresistance after exposure to low adapting IR doses. Although it is still unclear whether the adaptive response is beneficial or not to cells, survival of damaged cells after IR may lead to genomic instability in the descendants of surviving cells. Recent studies indicate a link between sCLU accumulation and cancer incidence, as well as aging, supporting involvement of the protein in the development of genomic instability. Secreted after IR, sCLU may also alter intracellular communication due to its ability to bind cell surface receptors, such as the TGF-beta receptors (types I and II). This interference with signaling pathways may contribute to IR-induced bystander effects. We hypothesize that activation of the TGF-beta signaling pathway, which often occurs after IR exposure, can in turn activate the CLU promoter. TGF-beta and IR-inducible de novo synthesized sCLU may then bind the TGF-beta receptors and suppress downstream growth arrest signaling. This complicated negative feedback regulation most certainly depends on the cellular microenvironment, but undoubtedly represents a potential link between IR-induced adaptive responses, genomic instability and bystander effects. Further elucidation of clusterin protein functions in IR responses are clearly warranted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530543     DOI: 10.1016/j.mrfmmm.2004.06.049

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  22 in total

1.  H2AX phosphorylation in response to DNA double-strand break formation during bystander signalling: effect of microRNA knockdown.

Authors:  Jennifer S Dickey; Franz J Zemp; Alvin Altamirano; Olga A Sedelnikova; William M Bonner; Olga Kovalchuk
Journal:  Radiat Prot Dosimetry       Date:  2010-12-23       Impact factor: 0.972

2.  Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Kolja Wawrowsky; Yuji Tani; Anat Ben-Shlomo; Vladimir Ljubimov; Adam Mamelak; Serguei Bannykh; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2012-10-09

3.  Identification of proteins secreted into the medium by human lymphocytes irradiated in vitro with or without adaptive environments.

Authors:  Kanokporn Noy Rithidech; Xianyin Lai; Louise Honikel; Paiboon Reungpatthanaphong; Frank A Witzmann
Journal:  Health Phys       Date:  2012-01       Impact factor: 1.316

4.  ATM-dependent IGF-1 induction regulates secretory clusterin expression after DNA damage and in genetic instability.

Authors:  E M Goetz; B Shankar; Y Zou; J C Morales; X Luo; S Araki; R Bachoo; L D Mayo; D A Boothman
Journal:  Oncogene       Date:  2011-04-04       Impact factor: 9.867

Review 5.  Radioadaptive response revisited.

Authors:  Soile Tapio; Vesna Jacob
Journal:  Radiat Environ Biophys       Date:  2006-11-28       Impact factor: 1.925

6.  TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo.

Authors:  Fanny Bouquet; Anupama Pal; Karsten A Pilones; Sandra Demaria; Byron Hann; Rosemary J Akhurst; Jim S Babb; Scott M Lonning; J Keith DeWyngaert; Silvia C Formenti; Mary Helen Barcellos-Hoff
Journal:  Clin Cancer Res       Date:  2011-10-25       Impact factor: 12.531

7.  Advances and challenges in basic and translational research on clusterin.

Authors:  Ioannis P Trougakos; Julie Y Djeu; Efstathios S Gonos; David A Boothman
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

8.  Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.

Authors:  Olesya Chayka; Daisy Corvetta; Michael Dews; Alessandro E Caccamo; Izabela Piotrowska; Giorgia Santilli; Sian Gibson; Neil J Sebire; Nourredine Himoudi; Michael D Hogarty; John Anderson; Saverio Bettuzzi; Andrei Thomas-Tikhonenko; Arturo Sala
Journal:  J Natl Cancer Inst       Date:  2009-04-28       Impact factor: 13.506

9.  Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells.

Authors:  Amina Zoubeidi; Susan Ettinger; Eliana Beraldi; Boris Hadaschik; Anousheh Zardan; Leo W J Klomp; Colleen C Nelson; Paul S Rennie; Martin E Gleave
Journal:  Mol Cancer Res       Date:  2010-01-12       Impact factor: 5.852

10.  Comparison in vivo Study of Genotoxic Action of High- Versus Very Low Dose-Rate gamma-Irradiation.

Authors:  A N Osipov; D Y Klokov; A L Elakov; O M Rozanova; S I Zaichkina; G F Aptikaeva; A Kh Akhmadieva
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.